ENTERA BIO LTD. Earnings Per Share (Basic)
ENTERA BIO LTD. (ENTX) reported Earnings Per Share (Basic) of $0.14 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- ENTERA BIO LTD. earnings per share, basic for the quarter ending 2026-06-30 was $0.14, a 133.33% increase year-over-year.
- ENTERA BIO LTD. earnings per share, basic for the quarter ending 2026-03-31 was $0.07, a 16.67% increase year-over-year.
- ENTERA BIO LTD. earnings per share, basic for the quarter ending 2025-12-31 was -$0.06.
- ENTERA BIO LTD. earnings per share, basic for the quarter ending 2025-09-30 was $0.07, a 12.50% decline year-over-year.
- ENTERA BIO LTD. earnings per share, basic for fiscal 2025 was $0.25, a 0.00% change from fiscal 2024.
- ENTERA BIO LTD. earnings per share, basic for fiscal 2024 was $0.25, a 19.35% decline from fiscal 2023.
- ENTERA BIO LTD. earnings per share, basic for fiscal 2023 was $0.31, a 31.11% decline from fiscal 2022.
- ENTERA BIO LTD. earnings per share, basic for fiscal 2022 was $0.45, a 4.26% decline from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.14 10-Q · filed 2026-08-07 | $0.22 10-Q · filed 2026-08-07 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-09-23 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-09-23 |
| 2026-03-31 | $0.07 10-Q · filed 2026-05-08 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-09-23 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-09-23 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-09-23 |
| 2025-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-09-23 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-09-23 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-09-23 | $0.25 10-K · filed 2026-03-27 |
| 2025-09-30 | $0.07 10-Q · filed 2025-11-14 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-08-07 | $0.18 10-Q · filed 2025-11-14 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-09-23 |
| 2025-06-30 | $0.06 10-Q · filed 2026-08-07 | $0.12 10-Q · filed 2026-08-07 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-09-23 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-09-23 |
| 2025-03-31 | $0.06 10-Q · filed 2026-05-08 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-09-23 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-09-23 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-09-23 |
| 2024-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-09-23 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-09-23 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-09-23 | $0.25 10-K · filed 2026-03-27 |
| 2024-09-30 | $0.08 10-Q · filed 2025-11-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-11-14 | $0.19 10-Q · filed 2025-11-14 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-11-14 |
| 2024-06-30 | $0.06 10-Q · filed 2025-08-08 | $0.11 10-Q · filed 2025-08-08 | -$0.18 derived: net income ÷ weighted average shares · filed 2025-08-08 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-08-08 |
| 2024-03-31 | $0.05 10-Q · filed 2025-05-09 | -$0.12 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$0.20 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$0.28 derived: net income ÷ weighted average shares · filed 2025-05-09 |
| 2023-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.15 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.23 derived: net income ÷ weighted average shares · filed 2025-03-28 | $0.31 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.08 10-Q · filed 2024-11-08 | -$0.16 derived: net income ÷ weighted average shares · filed 2024-11-08 | $0.24 10-Q · filed 2024-11-08 | -$0.34 derived: net income ÷ weighted average shares · filed 2024-11-08 |
| 2023-06-30 | $0.08 10-Q · filed 2024-08-09 | $0.16 10-Q · filed 2024-08-09 | -$0.26 derived: net income ÷ weighted average shares · filed 2024-08-09 | -$0.37 derived: net income ÷ weighted average shares · filed 2024-08-09 |
| 2023-03-31 | $0.08 10-Q · filed 2024-05-10 | -$0.18 derived: net income ÷ weighted average shares · filed 2024-05-10 | -$0.29 derived: net income ÷ weighted average shares · filed 2024-05-10 | -$0.40 derived: net income ÷ weighted average shares · filed 2024-05-10 |
| 2022-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2024-03-08 | -$0.21 derived: net income ÷ weighted average shares · filed 2024-03-08 | -$0.32 derived: net income ÷ weighted average shares · filed 2024-03-08 | $0.45 10-K · filed 2024-03-08 |
| 2022-09-30 | $0.11 10-Q · filed 2023-11-14 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-11-14 | $0.35 10-Q · filed 2023-11-14 | -$0.49 derived: net income ÷ weighted average shares · filed 2023-11-14 |
| 2022-06-30 | $0.11 10-Q · filed 2023-08-11 | $0.24 10-Q · filed 2023-08-11 | -$0.38 derived: net income ÷ weighted average shares · filed 2023-08-11 | -$0.50 derived: net income ÷ weighted average shares · filed 2023-08-11 |
| 2022-03-31 | $0.13 10-Q · filed 2023-05-05 | -$0.27 derived: net income ÷ weighted average shares · filed 2023-05-05 | -$0.39 derived: net income ÷ weighted average shares · filed 2023-05-05 | -$0.49 derived: net income ÷ weighted average shares · filed 2023-05-05 |
| 2021-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2023-03-31 | $0.47 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.11 10-Q · filed 2022-11-10 | -$0.22 derived: net income ÷ weighted average shares · filed 2022-11-10 | $0.32 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $0.10 10-Q · filed 2022-08-11 | $0.21 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |